Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Revue Neurologique|March 9, 2012
Recommendations for a definition of multiple sclerosis in support of early treatmentH Zéphir, E Bodiguel, C Bensa, et al.Revue Neurologique|June 5, 2012
Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosisC Bensa, E Bodiguel, D Brassat, et al.European Journal of Neurology|November 27, 2019
Antibody- and macrophage-mediated segmental demyelination in chronic inflammatory demyelinating polyneuropathy: clinical, electrophysiological, immunological and pathological correlatesJ-M Vallat, S Mathis, E Vegezzi, et al.Neurology|April 23, 2003
Interferon beta-1a as an investigational treatment for CIDPJ-M Vallat, A F Hahn, J-M Léger, et al.Clinics and Research in Hepatology and Gastroenterology|January 16, 2013
Acute liver toxicity due to methylprednisolone: consider this diagnosis in the context of autoimmunityP Carrier, B Godet, S Crepin, et al.La Revue De Medecine Interne|October 15, 2010
[Small fibre neuropathy in primary Sjögren syndrome]A-L Fauchais, L Richard, G Gondran, et al.European Journal of Neurology|February 18, 2017
Phenotypic spectrum of Charcot-Marie-Tooth disease due to LITAF/SIMPLE mutations: a study of 18 patientsR Guimarães-Costa, R Iancu Ferfoglia, S Leonard-Louis, et al.Clinical and Experimental Immunology|January 29, 2021
IVIg increases interleukin-11 levels, which in turn contribute to increased platelets, VWF and FVIII in mice and humansA Nguyen, Y Repesse, M Ebbo, et al.Neurology|May 11, 2005
The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2H H Klünemann, B H Ridha, L Magy, et al.Revue Neurologique|April 5, 2023
Current clinical management of CIDP with immunoglobulins in France: An expert opinionP Cintas, F Bouhour, C Cauquil, et al.Pageof 5